Stryker ROE 2006-2019 | SYK

Current and historical return on equity (ROE) values for Stryker (SYK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Stryker ROE for the three months ending March 31, 2019 was 26.72%.
Stryker ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $3.52B $11.69B 32.96%
2018-12-31 $3.55B $11.73B 35.29%
2018-09-30 $1.24B $9.86B 12.83%
2018-06-30 $1.08B $9.46B 11.05%
2018-03-31 $1.02B $9.22B 10.28%
2017-12-31 $1.02B $9.98B 10.16%
2017-09-30 $1.78B $10.43B 17.92%
2017-06-30 $1.70B $10.04B 17.61%
2017-03-31 $1.69B $9.70B 17.93%
2016-12-31 $1.65B $9.55B 17.91%
2016-09-30 $1.66B $9.33B 18.56%
2016-06-30 $1.61B $9.10B 18.39%
2016-03-31 $1.62B $8.81B 18.85%
2015-12-31 $1.44B $8.51B 17.02%
2015-09-30 $1.18B $8.48B 13.89%
2015-06-30 $0.93B $8.51B 10.96%
2015-03-31 $0.67B $8.32B 7.75%
2014-12-31 $0.52B $8.60B 5.84%
2014-09-30 $0.64B $8.62B 7.17%
2014-06-30 $0.69B $9.00B 7.67%
2014-03-31 $0.77B $9.06B 8.71%
2013-12-31 $1.01B $9.05B 11.55%
2013-09-30 $0.89B $8.74B 10.35%
2013-06-30 $1.14B $8.60B 13.41%
2013-03-31 $1.25B $8.46B 15.01%
2012-12-31 $1.30B $8.60B 15.77%
2012-09-30 $1.43B $8.36B 17.85%
2012-06-30 $1.40B $7.95B 17.98%
2012-03-31 $1.39B $8.02B 17.89%
2011-12-31 $1.35B $7.68B 17.66%
2011-09-30 $1.24B $7.56B 16.54%
2011-06-30 $1.25B $7.78B 16.82%
2011-03-31 $1.26B $7.45B 17.55%
2010-12-31 $1.27B $7.17B 18.25%
2010-09-30 $1.28B $7.31B 18.80%
2010-06-30 $1.18B $6.75B 17.78%
2010-03-31 $1.15B $6.67B 17.82%
2009-12-31 $1.11B $6.60B 17.91%
2009-09-30 $1.08B $6.44B 18.34%
2009-06-30 $1.12B $6.06B 19.69%
2009-03-31 $1.14B $5.63B 19.81%
2008-12-31 $1.15B $5.41B 19.72%
2008-09-30 $1.15B $5.75B 19.71%
2008-06-30 $1.10B $6.22B 19.43%
2008-03-31 $1.07B $5.93B 20.02%
2007-12-31 $1.02B $5.38B 20.54%
2007-09-30 $0.97B $5.16B 20.81%
2007-06-30 $0.93B $4.80B 21.27%
2007-03-31 $0.87B $4.49B 21.27%
2006-12-31 $0.78B $4.19B 20.16%
2006-09-30 $0.73B $3.99B 20.02%
2006-06-30 $0.66B $3.77B 19.34%
2006-03-31 $0.63B $3.49B 19.39%
2005-12-31 $0.64B $3.30B 20.94%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $78.520B $13.601B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.825B 29.16
Medtronic (MDT) Ireland $135.913B 19.41
Boston Scientific (BSX) United States $59.297B 28.43
Baxter (BAX) United States $42.385B 26.71
EssilorLuxottica Societe Anonyme (ESLOY) France $29.267B 0.00
Coloplast (CLPBY) Denmark $25.937B 41.41
Zimmer Biomet Holdings (ZBH) United States $25.411B 16.33
Lonza Group Ag (LZAGY) Switzerland $25.385B 0.00
Terumo (TRUMY) Japan $21.889B 25.17
Smith & Nephew SNATS (SNN) United Kingdom $19.108B 0.00
ResMed (RMD) United States $17.890B 34.18
Canopy Growth (CGC) Canada $12.379B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.239B 48.98
Insulet (PODD) United States $7.299B 531.83
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Hill-Rom Holdings (HRC) United States $7.083B 21.47
Aurora Cannabis (ACB) Canada $7.048B 69.50
Perrigo (PRGO) Ireland $6.991B 11.82
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.299B 51.41
ICU Medical (ICUI) United States $5.103B 30.45
GW Pharmaceuticals (GWPH) United Kingdom $5.007B 0.00
Neogen (NEOG) United States $3.388B 55.09
NuVasive (NUVA) United States $3.018B 24.64
Agios Pharmaceuticals (AGIO) United States $2.894B 0.00
Hutchison China MediTech (HCM) China $2.829B 0.00
National Vision Holdings (EYE) United States $2.507B 53.42
Quidel (QDEL) United States $2.307B 23.94
Aphria (APHA) $1.619B 0.00
Cardiovascular Systems (CSII) United States $1.549B 889.60
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.216B 0.00
VAREX IMAGING (VREX) United States $1.171B 24.86
NanoString Technologies (NSTG) United States $1.107B 0.00
Lantheus Holdings (LNTH) United States $1.086B 28.83
PetIQ (PETQ) United States $1.002B 24.33
Quanterix (QTRX) United States $0.820B 0.00
Cerus (CERS) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.35
Omeros (OMER) United States $0.760B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
TG Therapeutics (TGTX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.608B 29.43
Surmodics (SRDX) United States $0.538B 78.24
OraSure Technologies (OSUR) United States $0.525B 24.17
Meridian Bioscience (VIVO) United States $0.492B 15.03
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.465B 0.00
Vapotherm (VAPO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.324B 22.45
BioLife Solutions (BLFS) United States $0.319B 99.82
Cytosorbents (CTSO) United States $0.246B 0.00
Zynex (ZYXI) United States $0.239B 24.60
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.186B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.167B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.139B 7.32
Female Health (VERU) United States $0.138B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.25
MRI INTERVENTNS (MRIC) United States $0.052B 0.00